Summary
Agilent Technologies, Inc. reported solid revenue growth for the six months ended April 30, 2019, with total net revenue increasing by 4% to $2,522 million compared to the prior year. This growth was driven by strong performance in the Diagnostics and Genomics segment (+9%) and Agilent CrossLab (+8%), while the Life Sciences and Applied Markets segment remained flat. The company's net income for the six months was significantly impacted by a discrete tax benefit of $299 million related to Singapore tax incentives, resulting in a net income of $686 million, a substantial improvement from the net loss of $115 million in the prior year's comparable period which was affected by the U.S. Tax Cuts and Jobs Act. Operationally, Agilent maintained stable gross margins and operating margins, indicating effective cost management. The company also demonstrated a commitment to returning capital to shareholders through $104 million in dividends paid and $125 million in share repurchases during the first six months of the fiscal year. Agilent's strong cash position and newly established $1 billion credit facility provide ample liquidity for ongoing operations and strategic initiatives.
Financial Highlights
57 data points| Revenue | $1.24B |
| Cost of Revenue | $569.00M |
| Gross Profit | $669.00M |
| R&D Expenses | $99.00M |
| SG&A Expenses | $354.00M |
| Operating Expenses | $1.02B |
| Operating Income | $216.00M |
| Interest Expense | $17.00M |
| Net Income | $182.00M |
| EPS (Basic) | $0.57 |
| EPS (Diluted) | $0.57 |
| Shares Outstanding (Basic) | 317.00M |
| Shares Outstanding (Diluted) | 321.00M |
Key Highlights
- 1Total net revenue increased by 4% year-over-year for the six months ended April 30, 2019, reaching $2.52 billion.
- 2The Diagnostics and Genomics segment showed strong growth with a 9% increase in revenue year-over-year for the first six months.
- 3Agilent CrossLab segment revenue grew by 8% year-over-year for the first six months, driven by services and supplies.
- 4Net income for the six months ended April 30, 2019 was $686 million, significantly boosted by a $299 million discrete tax benefit.
- 5Operating margin remained stable at 18.5% for the six months ended April 30, 2019, indicating consistent operational performance.
- 6The company returned $104 million to shareholders through dividends and $125 million through share repurchases in the first six months of fiscal 2019.
- 7Agilent entered into a new $1 billion, five-year unsecured credit facility in March 2019, enhancing its liquidity position.